ClinConnect ClinConnect Logo
Search / Trial NCT06359808

Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis

Launched by XIJING HOSPITAL · Apr 6, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at the relationship between sleep disorders and ulcerative colitis (UC), a condition that causes inflammation of the intestines and can seriously impact a person's quality of life. The researchers want to understand how sleep problems might affect the gut's health, the nervous system, and other factors in patients with UC. Past studies have shown that many people with inflammatory bowel disease have trouble sleeping, which could make their symptoms worse and lead to a higher chance of flare-ups.

To participate in this study, individuals must have a diagnosis of ulcerative colitis and be willing to provide their complete medical history. However, those who have certain serious health issues, previous mental illnesses, or who are taking specific medications that influence heart rate or nervous system function won't be eligible. Participants will contribute to important research that could help improve understanding of how sleep quality affects people with ulcerative colitis, ultimately aiming to enhance their treatment and quality of life.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Ulcerative colitis was diagnosed according to the Consensus Opinions on the Diagnosis and Treatment of Inflammatory Bowel Disease (Beijing, 2018);
  • Complete medical records and signed informed consent.
  • Exclusion Criteria:
  • Previous mental illness or taking anti-anxiety and depression drugs;
  • Patients with malignant tumors of digestive system or serious diseases of organs such as heart, lung, liver and kidney function damage or diseases of blood system;
  • Drugs that affect heart rate or autonomic nervous function, such as glucocorticoids, beta-blockers, calcium channel blockers, etc. have been taken within the last 2 weeks;
  • People who smoke, drink alcohol, drink tea, and drink coffee within 24 hours (all stimulants, which can easily lead to excitement and affect heart rate variability);
  • Other diseases associated with autonomic nervous dysfunction (such as hyperthyroidism, hypertension, atrial premature beat, ventricular premature beat, pre-excitation syndrome, left bundle branch block, right bundle branch block, etc.).

About Xijing Hospital

Xijing Hospital, a prominent medical institution affiliated with the Fourth Military Medical University in Xi'an, China, is dedicated to advancing healthcare through innovative clinical research. Renowned for its comprehensive range of medical services and expertise in various specialties, Xijing Hospital actively sponsors clinical trials aimed at evaluating new therapies, improving patient outcomes, and contributing to scientific knowledge. With a commitment to ethical standards and patient safety, the hospital fosters collaboration among multidisciplinary teams to drive forward the development of effective treatment options that address critical health challenges.

Locations

Xi'an, Shaanxi, China

Patients applied

0 patients applied

Trial Officials

Kaichun Wu

Principal Investigator

Xijing Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported